FDA Drug Application (202718) for MORPHINE SULFATE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202718
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMORPHINE SULFATE
Active IngredientMORPHINE SULFATE

Active IngredientCount
List of drugs with Active Ingredient MORPHINE SULFATE11


Back to FDA Applications sponsored by TEVA PHARMS USA